The Journal of urology
The most recent articles from:
J. Urol.
-
The Journal of urology · Nov 2013
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure.
We report our experience with intravesical gemcitabine for bladder cancer after failed bacillus Calmette-Guérin treatment. ⋯ In our experience intravesical gemcitabine should be considered after bacillus Calmette-Guérin failure in patients with bladder cancer who refuse radical cystectomy or who are not candidates for major surgery.